2023
DOI: 10.1021/acsomega.3c02424
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic Targeting of Regulated Signaling Pathways of Non-Small Cell Lung Carcinoma

Abstract: Non-small cell lung carcinoma (NSCLC) is the most common cancer globally. Phytochemicals and small molecule inhibitors significantly prevent varying types of cancers, including NSCLC. These therapeutic molecules serve as important sources for new drugs that interfere with cellular proliferation, apoptosis, metastasis, and angiogenesis by regulating signaling pathways. These molecules affect several cellular signaling cascades, including p53, NF-κB, STAT3, RAS, MAPK/ERK, Wnt, and AKT/PI3K, and are thus implicat… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
6
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 155 publications
1
6
0
Order By: Relevance
“…The wound-healing assay conducted to assess the impact of CGA–CA on breast cancer cell migration revealed the ability of the phytochemicals to completely shut down the motility of both breast cancer cell types. Our CGA–CA treatment results are similar to findings of other phytochemical combinations’ impacts on breast and non-breast cancer cells, as previously reported in [ 37 , 59 , 60 , 61 ].…”
Section: Discussionsupporting
confidence: 90%
See 1 more Smart Citation
“…The wound-healing assay conducted to assess the impact of CGA–CA on breast cancer cell migration revealed the ability of the phytochemicals to completely shut down the motility of both breast cancer cell types. Our CGA–CA treatment results are similar to findings of other phytochemical combinations’ impacts on breast and non-breast cancer cells, as previously reported in [ 37 , 59 , 60 , 61 ].…”
Section: Discussionsupporting
confidence: 90%
“…Phytochemicals have been reported to modulate the Akt pathway in different types of cancer cells [ 13 , 60 , 61 , 65 ]. However, there are limitations to our study.…”
Section: Discussionmentioning
confidence: 99%
“…In melanoma, targeted therapy for molecules miR-21, miR-125b, miR-150, miR-155, miR-205, and miR-211 were searched with their prognostic value and processed to delete their onco-miRNA action. The foremost molecular deregulated cascades (e.g., MITF cascades, the p16INK4A-CDK4-RB cascades, the RAS/MAPK cascades and the PI3K-AKT) combine with miRNAs, thus give an insight about the metastatic and destructive features of melanoma [46].…”
Section: Discussionmentioning
confidence: 99%
“…The abnormal expression of the signal transducer and activator of transcription 3 (STAT3) is observed in various malignancies, including breast cancer, pancreatic cancer, leukemia, and liver cancer [ 1 , 2 , 3 , 4 , 5 ]. This transcription factor is involved in various cell activities, such as growth, proliferation, metastasis, and survival [ 6 , 7 ]. STAT3 is phosphorylated by the protein kinases Janus kinase 1/2 (JAK1/2) and Src, and STAT3 phosphorylation is inhibited by protein phosphatases such as SHP-1, SHP-2, and the protein tyrosine phosphatase (PTP) epsilon [ 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%